EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
NOTICE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - RECOMBINANT POLIOMYELITIS VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Monthly Return of Equity Issuer on Movements in Securities
INSIDE INFORMATION - NMPA OF CHINA GRANTS NDA APPROVAL TO PCV13i
POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - INHALED TB BOOSTER OBTAINS CLINICAL TRIAL APPROVAL IN INDONESIA
Form of Proxy for use at the 2024 Annual General Meeting to be held on Wednesday, June 4, 2025
1
2
3
4
5
6
47
津公网安备12011602300399
